Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis.
Diagnostic tests/Investigation
Drugs
Inflammation
Treatment Medical
Journal
The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
15
09
2020
revised:
15
08
2020
accepted:
22
08
2020
pubmed:
17
9
2020
medline:
15
2
2022
entrez:
16
9
2020
Statut:
ppublish
Résumé
To establish expert recommendations for the management of ocular sarcoidosis (OS). A question-based survey on the management of OS was circulated to international uveitis experts (members of the International Uveitis Study Group and the International Ocular Inflammation Society) electronically. Subsequently, a consensus workshop was conducted at the 7th International Workshop on Ocular Sarcoidosis (IWOS) in June 2019 in Sapporo, Japan as part of the Global Ocular Inflammation Workshops. Statements on the management of OS that were supported by a two-thirds majority of 10 international panel members of the workshop, after discussion and voting, were taken as consensus agreement. A total of 98 participants from 29 countries responded to the questionnaire survey. The subsequent consensus workshop established recommendations for the management of OS in five sections. The first section concerned evaluation and monitoring of inflammation. The second, third and fourth sections described ocular manifestations that were indications for treatment, and the management of anterior uveitis, intermediate uveitis and posterior uveitis. In the fifth section, the use of systemic corticosteroids and systemic immunosuppressive drugs were detailed. Recommendations for management of OS were formulated through an IWOS consensus workshop.
Identifiants
pubmed: 32933934
pii: bjophthalmol-2020-317354
doi: 10.1136/bjophthalmol-2020-317354
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1515-1519Informations de copyright
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.